Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
- PMID: 28689664
- PMCID: PMC5592248
- DOI: 10.1016/S0140-6736(17)30938-8
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
Abstract
Background: We have previously estimated that respiratory syncytial virus (RSV) was associated with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in 55 000 to 199 000 deaths in children younger than 5 years in 2005. In the past 5 years, major research activity on RSV has yielded substantial new data from developing countries. With a considerably expanded dataset from a large international collaboration, we aimed to estimate the global incidence, hospital admission rate, and mortality from RSV-ALRI episodes in young children in 2015.
Methods: We estimated the incidence and hospital admission rate of RSV-associated ALRI (RSV-ALRI) in children younger than 5 years stratified by age and World Bank income regions from a systematic review of studies published between Jan 1, 1995, and Dec 31, 2016, and unpublished data from 76 high quality population-based studies. We estimated the RSV-ALRI incidence for 132 developing countries using a risk factor-based model and 2015 population estimates. We estimated the in-hospital RSV-ALRI mortality by combining in-hospital case fatality ratios with hospital admission estimates from hospital-based (published and unpublished) studies. We also estimated overall RSV-ALRI mortality by identifying studies reporting monthly data for ALRI mortality in the community and RSV activity.
Findings: We estimated that globally in 2015, 33·1 million (uncertainty range [UR] 21·6-50·3) episodes of RSV-ALRI, resulted in about 3·2 million (2·7-3·8) hospital admissions, and 59 600 (48 000-74 500) in-hospital deaths in children younger than 5 years. In children younger than 6 months, 1·4 million (UR 1·2-1·7) hospital admissions, and 27 300 (UR 20 700-36 200) in-hospital deaths were due to RSV-ALRI. We also estimated that the overall RSV-ALRI mortality could be as high as 118 200 (UR 94 600-149 400). Incidence and mortality varied substantially from year to year in any given population.
Interpretation: Globally, RSV is a common cause of childhood ALRI and a major cause of hospital admissions in young children, resulting in a substantial burden on health-care services. About 45% of hospital admissions and in-hospital deaths due to RSV-ALRI occur in children younger than 6 months. An effective maternal RSV vaccine or monoclonal antibody could have a substantial effect on disease burden in this age group.
Funding: The Bill & Melinda Gates Foundation.
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5592248/bin/gr1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5592248/bin/gr2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5592248/bin/gr3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5592248/bin/gr4.gif)
Similar articles
-
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.Lancet. 2024 Mar 30;403(10433):1241-1253. doi: 10.1016/S0140-6736(24)00138-7. Epub 2024 Feb 14. Lancet. 2024. PMID: 38367641
-
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.Lancet. 2022 May 28;399(10340):2047-2064. doi: 10.1016/S0140-6736(22)00478-0. Epub 2022 May 19. Lancet. 2022. PMID: 35598608 Free PMC article. Review.
-
Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study.Lancet Glob Health. 2021 Jan;9(1):e33-e43. doi: 10.1016/S2214-109X(20)30393-4. Epub 2020 Nov 26. Lancet Glob Health. 2021. PMID: 33248481 Free PMC article.
-
Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study.Lancet Glob Health. 2020 Apr;8(4):e497-e510. doi: 10.1016/S2214-109X(19)30545-5. Epub 2020 Feb 20. Lancet Glob Health. 2020. PMID: 32087815 Free PMC article.
-
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.Lancet. 2010 May 1;375(9725):1545-55. doi: 10.1016/S0140-6736(10)60206-1. Lancet. 2010. PMID: 20399493 Free PMC article. Review.
Cited by
-
Efficacy of Respiratory Syncytial Virus Vaccination to Prevent Lower Respiratory Tract Illness in Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Vaccines (Basel). 2024 May 5;12(5):500. doi: 10.3390/vaccines12050500. Vaccines (Basel). 2024. PMID: 38793751 Free PMC article. Review.
-
Evolutionary trends of respiratory syncytial viruses: Insights from large-scale surveillance and molecular dynamics of G glycoprotein.Heliyon. 2024 May 9;10(10):e30886. doi: 10.1016/j.heliyon.2024.e30886. eCollection 2024 May 30. Heliyon. 2024. PMID: 38784562 Free PMC article.
-
Enrichment approach for unbiased sequencing of respiratory syncytial virus directly from clinical samples.Wellcome Open Res. 2021 May 7;6:99. doi: 10.12688/wellcomeopenres.16756.1. eCollection 2021. Wellcome Open Res. 2021. PMID: 38779569 Free PMC article.
-
Respiratory viral infections before the COVID-19 in Portugal: A single center study.Heliyon. 2024 May 9;10(10):e30894. doi: 10.1016/j.heliyon.2024.e30894. eCollection 2024 May 30. Heliyon. 2024. PMID: 38778982 Free PMC article.
-
The Multifaceted Burden of Respiratory Syncytial Virus (RSV) Infections in Young Children on the Family: A European Study.Infect Dis Ther. 2024 Jul;13(7):1531-1573. doi: 10.1007/s40121-024-00989-0. Epub 2024 May 20. Infect Dis Ther. 2024. PMID: 38767780 Free PMC article.
References
-
- Mazur NI, Martinon-Torres F, Baraldi E. Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med. 2015;3:888–900. - PubMed
-
- WHO . The World Health Organization Product Development for Vaccines Advisory Committee (PDVAC) 7–9 Sep 2015: Initial Summary. World Health Organization; Geneva: 2015.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous